| |
|
|
|
Entera Bio Ltd  
|
|
5.13 -0.08 (-0.02%) |
09-28 16:00 |
|
Open: |
5.18 |
Pre close: |
5.21 |
Target:
|
6.30
|
|
High: |
5.2 |
Low: |
4.87 |
Resistance:
|
5.39
6.30
|
|
Volume: |
207,632 |
Market Cap: |
148M |
Support:
|
4.79
4.42
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.97
 |
MACD |
MACD(12,26):
|
-0.00 |
|
MA(20): |
4.83 |
Signal(12,26,9): |
-0.06 |
|
MA(100): |
4.67 |
Stochastic Oscillator |
%K(14,3):
|
78.31 |
|
MA(250): |
3.05 |
%D(3): |
63.60 |
|
Average Volume(K) |
3-Month: |
793405
|
52-Week |
High:
|
10.16 |
|
10-Days: |
11198 |
Low: |
1.01 |
|
RSI |
RSI(14):
|
56.95  |
Change(%): |
313.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.862 |
Return on Equity (ttm) |
-187.8 |
Shares Out. (M) |
23.78 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-40.5 |
Shares Float (M) |
13.62 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
31.53 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
273.8 |
% Held by Institutions |
23.73 |
|
Forward EPS |
1.310 |
Gross Profit (p.s.) |
0.007 |
Shares Short (K) |
119 |
|
Book Value (p.s.) |
0.320 |
EBITDA (p.s.) |
-0.454 |
P/E |
-5.95 |
|
Sales Per Share |
0.020 |
Qtrly Earnings Growth |
0.00 |
P/BV |
16.03 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-10.04 |
P/S |
254.15 |
|
Operating Margin |
-2273.13 |
Levered Free Cash Flow
(M) |
-0.41 |
P/CF |
-12.15 |
|
|
|
|
|
|
